Camila Gazolla Volpiano (PhD)
Microbial Bioinformatics
Camila Gazolla Volpiano (PhD)
Microbial Bioinformatics
Embedded Files
Microbial Bioinformatics
PhD, MSc Genetics & Mol Biology | Postdoc Microbial Bioinformatician @ Baker | Adjunct RA @ Monash | Honorary Fellow @ UniMelb
I am a postdoctoral researcher at the Méric Lab from the Baker Heart & Diabetes Institute (Melbourne, Australia). My current research involves the analysis of microbial features within extensively phenotyped large human cohort studies, with a focus on both incident and prevalent health.
I am a postdoctoral researcher at the Méric Lab from the Baker Heart & Diabetes Institute (Melbourne, Australia). My current research involves the analysis of microbial features within extensively phenotyped large human cohort studies, with a focus on both incident and prevalent health.
_______________
Biography
Biography
I grew up in the South Region of Brazil and began my undergraduate studies in Biotechnology at the Federal University of Paraná (UFPR) in 2012. Within my first months on campus, I joined a microbiology wet lab working on plant growth-promoting bacteria. I went on to complete an MSc (2017) and PhD (2021) in Genetics and Molecular Biology at the Federal University of Rio Grande do Sul (PPGBM/UFRGS), the country’s oldest and one of the most recognised postgraduate programmes in the field.
I grew up in the South Region of Brazil and began my undergraduate studies in Biotechnology at the Federal University of Paraná (UFPR) in 2012. Within my first months on campus, I joined a microbiology wet lab working on plant growth-promoting bacteria. I went on to complete an MSc (2017) and PhD (2021) in Genetics and Molecular Biology at the Federal University of Rio Grande do Sul (PPGBM/UFRGS), the country’s oldest and one of the most recognised postgraduate programmes in the field.
At UFRGS, I worked with the SEMIA Culture Collection (>1,200 agriculturally important bacterial strains used as plant inoculants that underpin Brazil’s successful crop-inoculation programme) and shifted decisively into computational biology, focusing on bacterial genomics. During my PhD, I secured support from the U.S. Department of Energy’s GEBA-IV initiative to sequence the collection’s common-bean strain subset.
At UFRGS, I worked with the SEMIA Culture Collection (>1,200 agriculturally important bacterial strains used as plant inoculants that underpin Brazil’s successful crop-inoculation programme) and shifted decisively into computational biology, focusing on bacterial genomics. During my PhD, I secured support from the U.S. Department of Energy’s GEBA-IV initiative to sequence the collection’s common-bean strain subset.
From 2019 to 2022, I co-founded and co-led Agrega Pesquisa e Desenvolvimento em Biotecnologia, building workflows for (meta)genomics and (meta)barcoding analysis and securing competitive innovation grants, before returning to curiosity-driven research. In 2022, I moved to New York (USA) as a postdoctoral fellow at the Albert Einstein College of Medicine, and in 2023 I was recruited to the Baker Heart and Diabetes Institute in Melbourne (Australia) to work with Dr Guillaume Méric, where I now study links between the human microbiome and health in large, deeply phenotyped cohorts.
From 2019 to 2022, I co-founded and co-led Agrega Pesquisa e Desenvolvimento em Biotecnologia, building workflows for (meta)genomics and (meta)barcoding analysis and securing competitive innovation grants, before returning to curiosity-driven research. In 2022, I moved to New York (USA) as a postdoctoral fellow at the Albert Einstein College of Medicine, and in 2023 I was recruited to the Baker Heart and Diabetes Institute in Melbourne (Australia) to work with Dr Guillaume Méric, where I now study links between the human microbiome and health in large, deeply phenotyped cohorts.
My recent work spans three main projects: (i) investigating how past infections predispose individuals to non-communicable diseases by exploring data from multiple population-based cohorts; (ii) characterising the ecological diversity and clinical associations of human gut archaea; and (iii) exploring bacterial diversity and strain persistence in the infant respiratory microbiome over the first year of life.
My recent work spans three main projects: (i) investigating how past infections predispose individuals to non-communicable diseases by exploring data from multiple population-based cohorts; (ii) characterising the ecological diversity and clinical associations of human gut archaea; and (iii) exploring bacterial diversity and strain persistence in the infant respiratory microbiome over the first year of life.
I also hold honorary appointments with the University of Melbourne and Monash University, and maintain active collaborations across the UK, Finland, Sweden and Austria.
I also hold honorary appointments with the University of Melbourne and Monash University, and maintain active collaborations across the UK, Finland, Sweden and Austria.
Positions and qualifications:
- 2023-(now) Postdoc, Baker Heart & Diabetes Institute, Melbourne, Australia
- 2022-Postdoc, Albert Einstein College of Medicine, New York, USA
- 2019-2022 Co-founder and CTO, Agrega Pesquisa e Desenvolvimento em Biotecnologia, Brazil
- 2018-2021 PhD (Genetics and Molecular Biology). Federal University Rio Grande do Sul, Brazil
- 2016-2017 MSc (Genetics and Molecular Biology). Federal University Rio Grande do Sul, Brazil
- 2012-2015 BTech (Biotechnology). Federal University of Paraná, Brazil
Page updated
Google Sites
Report abuse